Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.) Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.
Frequently asked questions
What sector does DNA Biomed Solns (DNA) operate in?
DNA Biomed Solns belongs to the Information Technology sector and operates in the Lodging industry.
What is DNA Biomed Solns (DNA) current stock price?
As of the latest data, DNA Biomed Solns stock price is ₪1.03, with a previous close of ₪1.03.
What is DNA Biomed Solns (DNA) current market capitalization?
DNA Biomed Solns market cap is approximately 851.73 million.
Does DNA Biomed Solns (DNA) pay dividends?
No. DNA Biomed Solns does not pay a dividend.
What is DNA Biomed Solns (DNA) beta (volatility) score?
DNA Biomed Solns has a beta of -0.008, indicating lower volatility than the overall market.
